Literature DB >> 15505374

Rodent Abeta(1-42) exhibits oxidative stress properties similar to those of human Abeta(1-42): Implications for proposed mechanisms of toxicity.

Debra Boyd-Kimball1, Rukhsana Sultana, Hafiz Mohmmad-Abdul, D Allan Butterfield.   

Abstract

Alzheimer's disease is a neurodegenerative disorder associated with aging and cognitive decline. Amyloid beta peptide (1-42) [Abeta(1-42)] is a primary constituent of senile plaques - a hallmark of Alzheimer's disease - and has been implicated in the pathogenesis of the disease. Previous studies have shown that methionine residue 35 of beta(1-42) may play a critical role in Abeta(1-42)-mediated oxidative stress and neurotoxicity. Several additional mechanisms of neurotoxicity have been proposed, including the role of Cu(II) binding and reduction to produce hydrogen peroxide and the role of peptide aggregation. It has been reported that rodent Abeta is less likely to form larger beta-sheet structures, and consequently, large aggregates. As a consequence of the lack of deposition of the peptide in rodent brain, rodent Abeta has been proposed to be non-toxic. Additionally, the sequence of the rodent variety of Abeta(1-42) contains three amino acid substitutions compared to the human sequence. These substitutions include the shift of arginine 5, trysosine 10, and histidine 13 to glycine, phenylalanine, and arginine, respectively. This shift in sequence within the Cu(II) binding region of the peptide results in a decrease in the ability of the rodent Abeta peptide to reduce Cu(II) to Cu(I) compared to the human Abeta peptide. As a result of the effect of the amino acid variations on the ability of the rodent peptide to reduce Cu(II) to Cu(I) compared to the human peptide, the rodent beta has been proposed to lack oxidative stress properties. In this study, the oxidative stress and neurotoxic properties of rodent beta(1-42) [Abeta(1-42)Rat] were evaluated and compared to those of human Abeta(1-42). Both human Abeta(1-42) and beta(1-42)Rat were found to have a significant effect on neuronal DNA fragmentation, loss of neuritic networks, and cell viability. beta(1-42) Rat was found to cause a significant increase in both protein oxidation and lipid peroxidation, similar to Abeta(1-42), both of which were inhibited by the lipid-soluble, chain breaking antioxidant vitamin E, suggesting that reactive oxygen species play a role in the Abeta-mediated toxicity. Taken together, these results suggest that Cu(II) reduction may not play a critical role inbeta(1-42)Rat-induced oxidative stress, and that the oxidative stress exhibited by this peptide may be a consequence of the presence of methionine 35, similar to the findings associated with the native human beta(1-42) peptide.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15505374     DOI: 10.3233/jad-2004-6509

Source DB:  PubMed          Journal:  J Alzheimers Dis        ISSN: 1387-2877            Impact factor:   4.472


  22 in total

Review 1.  Abeta, oxidative stress in Alzheimer disease: evidence based on proteomics studies.

Authors:  Aaron M Swomley; Sarah Förster; Jierel T Keeney; Judy Triplett; Zhaoshu Zhang; Rukhsana Sultana; D Allan Butterfield
Journal:  Biochim Biophys Acta       Date:  2013-10-09

Review 2.  Redox proteomics in some age-related neurodegenerative disorders or models thereof.

Authors:  D Allan Butterfield; Hafiz Mohmmad Abdul; Shelley Newman; Tanea Reed
Journal:  NeuroRx       Date:  2006-07

Review 3.  Primate aging in the mammalian scheme: the puzzle of extreme variation in brain aging.

Authors:  Caleb E Finch; Steven N Austad
Journal:  Age (Dordr)       Date:  2012-01-05

4.  The APOE4 allele shows opposite sex bias in microbleeds and Alzheimer's disease of humans and mice.

Authors:  Mafalda Cacciottolo; Amy Christensen; Alexandra Moser; Jiahui Liu; Christian J Pike; Conor Smith; Mary Jo LaDu; Patrick M Sullivan; Todd E Morgan; Egor Dolzhenko; Andreas Charidimou; Lars-Olof Wahlund; Maria Kristofferson Wiberg; Sara Shams; Gloria Chia-Yi Chiang; Caleb E Finch
Journal:  Neurobiol Aging       Date:  2015-10-19       Impact factor: 4.673

5.  Amyloid beta and the longest-lived rodent: the naked mole-rat as a model for natural protection from Alzheimer's disease.

Authors:  Yael H Edrey; David X Medina; Maria Gaczynska; Pawel A Osmulski; Salvatore Oddo; Antonella Caccamo; Rochelle Buffenstein
Journal:  Neurobiol Aging       Date:  2013-04-22       Impact factor: 4.673

Review 6.  Roles of amyloid beta-peptide-associated oxidative stress and brain protein modifications in the pathogenesis of Alzheimer's disease and mild cognitive impairment.

Authors:  D Allan Butterfield; Tanea Reed; Shelley F Newman; Rukhsana Sultana
Journal:  Free Radic Biol Med       Date:  2007-06-13       Impact factor: 7.376

Review 7.  Apolipoprotein E and Sex Bias in Cerebrovascular Aging of Men and Mice.

Authors:  Caleb E Finch; Sara Shams
Journal:  Trends Neurosci       Date:  2016-08-18       Impact factor: 13.837

8.  Mutual stimulation of beta-amyloid fibrillogenesis by clioquinol and divalent metals.

Authors:  Silvia Bolognin; Paolo Zatta; Denise Drago; Giuseppe Tognon; Pier Paolo Parnigotto; Fernanda Ricchelli
Journal:  Neuromolecular Med       Date:  2008-08-19       Impact factor: 3.843

9.  BACE-1 is expressed in the blood-brain barrier endothelium and is upregulated in a murine model of Alzheimer's disease.

Authors:  Kavi Devraj; Slobodan Poznanovic; Christoph Spahn; Gerhard Schwall; Patrick N Harter; Michel Mittelbronn; Katia Antoniello; Paolo Paganetti; Andreas Muhs; Mike Heilemann; Richard A Hawkins; André Schrattenholz; Stefan Liebner
Journal:  J Cereb Blood Flow Metab       Date:  2015-10-13       Impact factor: 6.200

10.  Coenzyme Q10 attenuates beta-amyloid pathology in the aged transgenic mice with Alzheimer presenilin 1 mutation.

Authors:  Xifei Yang; Ying Yang; Geng Li; Jianzhi Wang; Edward S Yang
Journal:  J Mol Neurosci       Date:  2008-01-05       Impact factor: 3.444

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.